Use of antibiotics in children: a Danish nationwide drug utilization study

Anton Pottegård1, Anne Broe, Rune Aabenhus

  • 1From the *Clinical Pharmacology, Department of Public Health, University of Southern Denmark; †Department of Clinical Chemistry and Pharmacology, Odense University Hospital; and ‡Section of General Practice and Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Insights

Antibiotic prescribing for children in Denmark remained high and stable from 2000-2012. While broad-spectrum penicillin use increased, antibiotic choices generally followed national guidelines.

Area of Science:

  • Pediatric pharmacology
  • Public health surveillance
  • Infectious disease epidemiology

Background:

  • Systemic antibiotic use in pediatric populations is a significant public health concern.
  • Understanding national prescribing patterns is crucial for antimicrobial stewardship.

Purpose of the Study:

  • To describe the utilization of systemic antibiotics in children in Denmark.
  • To analyze trends and patterns in pediatric antibiotic prescriptions over a 13-year period.

Main Methods:

  • Utilized national prescription data from the Danish National Prescription Database.
  • Included all children aged 0-11 years in Denmark from January 1, 2000, to December 31, 2012.

Main Results:

  • Over 5.8 million antibiotic prescriptions were issued to over 1.2 million children.
  • Phenoxymethylpenicillin (45%) and amoxicillin (34%) were the most prescribed antibiotics.
  • Highest incidence rates were in children under 2 years old, with a shift towards broader-spectrum amoxicillin in younger children.

Conclusions:

  • Pediatric antibiotic prescribing rates in Denmark remained consistently high between 2000 and 2012.
  • An increase in broad-spectrum beta-lactam penicillin use was observed.
  • Prescribing patterns largely aligned with national guidelines regarding antibiotic selection.
Abstract

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
48.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
399
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
202
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
84
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
954